Workflow
Alumni Capital LP
icon
Search documents
RedHill Biopharma(RDHL) - Prospectus(update)
2026-01-22 21:04
Israel 2834 Not Applicable (Primary Standard Industrial Classification Code Number) As filed with the Securities and Exchange Commission on January 22, 2026 Registration No. 333-292528 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REDHILL BIOPHARMA LTD. (Exact name of Registrant as specified in its charter) Not Applicable (Translation of Registrant's name into English) (State or other jurisdiction o ...
Treasure Global Concludes Alumni Capital Equity Line Facility to Streamline Capital Structure and Focus on Fintech & Digital-Asset Growth
Globenewswire· 2026-01-06 13:03
Core Insights - Treasure Global Inc. has concluded its equity line facility with Alumni Capital LP, resulting in no further dilution for the company [1][3] - The equity line facility, established under a Purchase Agreement, provided discretionary access to equity financing until December 31, 2025 [2] - The completion of the facility allows the company to focus on scaling its OXI Wallet and advancing its UNIRWA real-world-asset initiatives without additional financial obligations [4] Company Overview - Treasure Global is a technology solutions provider based in Malaysia, specializing in platforms that drive digital transformation in retail and services [5] - The company's flagship product, the ZCITY Super App, integrates e-payment solutions with customer loyalty rewards, boasting over 2.7 million registered users as of June 2025 [5] - The company leverages advanced technologies such as artificial intelligence and data analytics to enhance its capabilities across e-commerce and fintech sectors [5]
RedHill Biopharma(RDHL) - Prospectus
2025-12-31 22:09
Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 As filed with the Securities and Exchange Commission on December 31, 2025 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REDHILL BIOPHARMA LTD. (Exact name of Registrant as specified in its charter) Not Applicable (Translation of Registrant's name into English) (Address, including zip code, and telephone number, including area code, of Registrant's principal executive offices) RedHill Biopharma In ...
NextTrip, Inc.(NTRP) - Prospectus(update)
2025-07-29 20:56
As filed with the Securities and Exchange Commission on July 29, 2025. Registration No. 333-288212 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NEXTTRIP, INC. (Exact name of registrant as specified in its charter) (State or Other Jurisdiction of Incorporation) Nevada 4724 27-1865814 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification No.) 3900 Paseo del Sol Sant ...
Sigma Additive Solutions(SASI) - Prospectus(update)
2025-07-29 20:56
(State or Other Jurisdiction of Incorporation) Registration No. 333-288212 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NEXTTRIP, INC. (Exact name of registrant as specified in its charter) As filed with the Securities and Exchange Commission on July 29, 2025. If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the followin ...
VCI Global Revises Equity Agreement with 102% Premium Pricing, Enhancing Strategic Flexibility
Globenewswire· 2025-05-22 21:00
Core Insights - VCI Global Limited has amended its equity line agreement with Alumni Capital LP, emphasizing a disciplined capital strategy and commitment to long-term shareholder value [1][2][4] Capital Structure - Future equity issuances to Alumni Capital will now be priced at 102% of the lowest trading price over the preceding five trading days, an increase from the previous pricing of 85%, indicating enhanced institutional confidence [2][7] - The revised terms aim to minimize dilution for existing shareholders while allowing the company to act decisively in capital deployment [4][7] Financial Strategy - The amended capital agreement serves as a liquidity reserve, enabling VCI Global to pursue strategic acquisitions and respond to market dynamics while retaining full discretion over drawdowns [3][7] - The company has access to approximately US$112 million under the facility, which can be utilized strategically to support growth initiatives [7] Growth Focus - The changes in the capital structure align with VCI Global's aggressive expansion into sectors such as AI infrastructure, cybersecurity, and capital markets advisory, while maintaining financial flexibility [7]
Brazil Potash Announces Agreement for up to $75 Million Equity Line of Credit From Alumni Capital
Globenewswire· 2025-05-06 10:45
Core Viewpoint - Brazil Potash Corp has entered into a definitive agreement for an equity line of credit with Alumni Capital LP, which is expected to provide flexible funding for the Autazes Potash Project, crucial for global food security [1][3]. Funding Agreement - The equity line of credit allows Brazil Potash to sell up to $75 million worth of common shares over a 24-month period, with the company controlling the timing and amount of sales [3]. - The agreement is structured to provide Brazil Potash with a flexible financing tool as it progresses with early construction activities for the Autazes Project [2][3]. Project Overview - The Autazes Project aims to supply sustainable fertilizers to Brazil, which is heavily reliant on potash imports, having imported over 95% of its potash fertilizer in 2021 [6]. - Brazil Potash plans to produce up to 2.4 million tons of potash annually, potentially meeting approximately 20% of Brazil's current potash demand [6]. - The project is positioned to reduce Brazil's reliance on imports and mitigate around 1.4 million tons of greenhouse gas emissions per year [6].
Steakholder Foods® Announces $1.25 Million Private Placement and $8 Million Equity Line of Credit Funding Mechanism
Newsfilter· 2025-02-28 14:00
Core Viewpoint - Steakholder Foods Ltd. has entered into definitive agreements for a private placement with Alumni Capital LP, raising approximately $1.25 million through the sale of American Depositary Shares (ADSs) and warrants, aimed at supporting its strategic growth initiatives [1][2][4]. Group 1: Private Placement Details - The company will sell 985,028 ADSs at a purchase price of $1.269 per ADS, with warrants to purchase an equal number of ADSs at an exercise price of $2.00, which will be immediately exercisable and expire in five years [1][2]. - The gross proceeds from this offering are expected to be around $1.25 million before deducting offering expenses, with the net proceeds intended for working capital and general corporate purposes [2]. Group 2: Equity Line of Credit - Steakholder Foods has established an equity line of credit (ELOC) with Alumni Capital LP, providing a flexible funding mechanism to support its growth while minimizing dilution to existing shareholders [4][5]. - The structure of the ELOC allows the company to maintain control over the timing and amount of equity sales, ensuring financial stability and strategic flexibility [5]. Group 3: Management Commentary - The CEO of Steakholder Foods emphasized that the agreements with Alumni Capital represent a significant milestone in the company's growth strategy, providing immediate funds for continued strategic growth while mitigating dilution [6]. - The Portfolio Manager at Alumni Capital expressed confidence in the company's vision and management team, indicating a commitment to support Steakholder Foods in driving sustainable value creation [6]. Group 4: Company Overview - Steakholder Foods specializes in alternative proteins and 3D printing technologies, focusing on developing and selling production machines that enable efficient food manufacturing [8]. - The company aims to create products that replicate the textures of traditional meats and is exploring the integration of cultivated cells for future advancements in food technology [9].
Adial Pharmaceuticals(ADIL) - Prospectus
2023-06-23 01:38
As filed with the Securities and Exchange Commission on June 22, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ADIAL PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 8071 82-3074668 (I.R.S. Employer Identification No.) Adial Pharmaceutic ...